Tech Center 1600 • Art Units: 1600 1644 1675
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18268009 | CLASS OF BIOMATERIALS FOR PROMOTING LARGE BLOOD VESSEL GROWTH | Non-Final OA | Vanderbilt University |
| 18255503 | PREVENTION AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) | Non-Final OA | CITY OF HOPE |
| 18264475 | Formulations of DR5 Binding Polypeptides | Non-Final OA | Inhibrx Biosciences, Inc. |
| 18274668 | IL-15 FUSION PROTEINS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Salubris Biotherapeutics, Inc. |
| 18270472 | FORMULATIONS OF ANTI-CD73 ANTIBODIES | Non-Final OA | I-MAB BIOPHARMA US LIMITED |
| 18174127 | IMMUNOASSAYS FOR DETECTING WILD TYPE HUNTINGTIN PROTEIN AND METHODS OF TREATMENT EMPLOYING SUCH IMMUNOASSAYS | Non-Final OA | WAVE LIFE SCIENCES LTD. |
| 18033773 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA | Non-Final OA | Cytune Pharma |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy